RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Apixaban Superior to Warfarin for Prevention of SSE in Patients with AF: Results from ARISTOTLE
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 10
SP 11
OP 12
DO 10.1177/155989771110003
UL http://mdc.sagepub.com/content/11/10/11.abstract
AB In patients with atrial fibrillation, apixaban is superior to warfarin in preventing stroke or systemic embolism, causes less bleeding, and results in lower mortality according to primary results from the Apixaban for Reduction In STrOke and other ThromboemboLic Events in atrial fibrillation [ARISTOTLE; NCT00412984] trial.